 The study found that preoperative fasting C-peptid, HBA1C, FPG and BMI levels can predict the likelihood of remission in patients with type 2 diabetes following bariatric surgery. Specifically, fasting C-peptid was associated with increased chance of remission while FPG and HBA1C were associated with reduced odds of remission. BMI was not found to be associated with remission. These findings suggest that these parameters may be used as a guideline in weighing the risks and benefits for surgical intervention in patients with type 2 diabetes. This article was authored by Wen Mao Yang, Wixing Bai, Ming Yang and others.